Profil
Aram Andrew Mangasarian currently works at NOXXON Pharma AG, as Chief Executive Officer & Non-Executive Director from 2015, NOXXON Pharma NV Niederlassung Deutschland, as Director, and TME Pharma NV, as Chief Scientific Officer from 2025.
Dr. Mangasarian also formerly worked at Caerus Consulting AS, as Director, Isofol Medical AB, as Independent Director from 2020 to 2023, Novexel SA, as Vice President-Development Affairs from 2005 to 2012, Exonhit, as Manager from 2000 to 2012, and Eurobio-Scientific SA, as Vice President-Business Development.
Dr. Mangasarian received his undergraduate degree from the University of Wisconsin, Masters Business Admin degree from INSEAD, and doctorate degree from the University of California San Diego.
Postes actifs de Aram Andrew Mangasarian
| Sociétés | Poste | Début |
|---|---|---|
| TME PHARMA N.V. | Directeur Technique/Scientifique/R&D | 25/06/2025 |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology Provides drug discovery and development services | Directeur Général | 01/05/2010 |
NOXXON Pharma NV Niederlassung Deutschland
NOXXON Pharma NV Niederlassung Deutschland BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Anciens postes connus de Aram Andrew Mangasarian
| Sociétés | Poste | Fin |
|---|---|---|
| ISOFOL MEDICAL AB | Directeur/Membre du Conseil | 01/02/2023 |
| EUROBIO SCIENTIFIC | Corporate Officer/Principal | - |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceuticals | Corporate Officer/Principal | - |
Caerus Consulting AS
Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Develops antibiotics to treat life threatening bacterial diseases | Directeur/Membre du Conseil | - |
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Researches and develops anti-infective drugs for the treatment of bacterial and fungal infections | Corporate Officer/Principal | - |
Formation de Aram Andrew Mangasarian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Researches and develops anti-infective drugs for the treatment of bacterial and fungal infections | Health Technology |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology Provides drug discovery and development services | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceuticals | Health Technology |
Caerus Consulting AS
Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Develops antibiotics to treat life threatening bacterial diseases | Health Technology |
Isofol Medical AB
Isofol Medical AB Pharmaceuticals: MajorHealth Technology Provides novel folate-based pharmaceutical products | Health Technology |
Eurobio-Scientific SA
Eurobio-Scientific SA Medical SpecialtiesHealth Technology Develops and distributes medical diagnosis tool kits | Health Technology |
TME Pharma NV
TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
NOXXON Pharma NV Niederlassung Deutschland
NOXXON Pharma NV Niederlassung Deutschland BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















